Kiran Sapkota, Ph.D.
Kiran Sapkota, Ph.D., received his Bachelor’s of Science in Pharmaceutical Science from Pokhara University, Nepal, in 2006. He next obtained Master’s of Science degrees in both Medicinal Chemistry from the Catholic University of Daegu, South Korea, in 2009 and in Pharmacology from Creighton University, Nebraska, in 2012. He obtained a Ph.D. in 2016 from the University of Nebraska Medical Center under the mentorship of Daniel T. Monaghan, Ph.D., with a focus on the development of NMDA receptor modulators with potential applications in neuropsychiatric diseases, such as schizophrenia and autism spectrum disorder. After completion of his Doctorate, he continued his research in the same lab as a postdoctoral trainee for two years, during which he characterized and studied the mechanism of action of NMDA receptor modulators using various techniques such as two-electrode voltage clamp electrophysiology (Xenopus oocytes) and FLIPR, a Ca2+ imaging assay (HEK cells). After that, he joined Dr. Nakazawa’s lab in 2018 as a postdoctoral researcher. His current research goal is to identify the role of NMDARs, particularly in GABAergic interneurons, in the pathophysiology of neuropsychiatric disorders.